Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine and TBI for Second SCT After Graft Rejection
NCT00472329Phase 2Unknown
- Sponsor
- Colorado Blood Cancer Institute
- Start
- Mar 2007
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in Graft failure, sponsored by Colorado Blood Cancer Institute. Status: unknown.
02
Drugs
fludarabine
03
Conditions
Graft failure
Beyond the preview
Go deeper on NCT00472329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472329.